Connexin 43 (cx43) enhances chemotherapy-induced apoptosis in human glioblastoma cells

International Journal of Cancer

Volumn 92, Issue 1, 2001, Pages 130-138

  Huang, Ruo Pan ^a,b   Hossain, Moharmmad Z ^b   Huang, Ruochun ^a   Gano, Jacob ^b   Fan, Yan ^a,b   Boynton, Alton L ^b  

^a EMORY UNIVERSITY SCHOOL OF MEDICINE   (United States)

^b NORTHWEST HOSPITAL   (United States)

Author keywords

Apoptosis; Bcl 2; Chemotherapy; Connexin 43; Glioblastoma

Indexed keywords

CONNEXIN 43; DOXORUBICIN; ETOPOSIDE; LIPOCORTIN 5; PACLITAXEL; PROTEIN BCL 2;

APOPTOSIS; ARTICLE; CANCER CHEMOTHERAPY; CARCINOGENICITY; CELL COMMUNICATION; CELL TRANSFORMATION; CONTROLLED STUDY; DRUG SENSITIVITY; GAP JUNCTION; GENETIC TRANSFECTION; GLIOBLASTOMA; HUMAN; HUMAN CELL; PRIORITY JOURNAL; PROTEIN EXPRESSION;

EID: 0035314016     PISSN: 00207136     EISSN: None     Source Type: Journal    
DOI: 10.1002/1097-0215(200102)9999:9999<::AID-IJC1165>3.0.CO;2-G     Document Type: Article

References (52)

1. Role of cnnnexin genes in growth control
2. Cardiac malformation in neonatal mice lacking connexin43
3. Connexin43 reverses the phenotype of transformed cells and alters their expression of cyclin/ cyclin-dependent kinases
4. Reversion of the neoplastic phenotype of human glioblastoma cells by connexin 43 (cx43)
5. Transcriptional down-regulation of gap junction proteins blocks junctional communication in human mammary tumor cell lines
6. Specificity of gap junction communication among human mammary cells and connexin transfections in culture
7. Reduced connexin43 expression in high grade, human prostatic adenocarcinoma cells
8. Expression of cx26, cx32 and cx43 gap junction proteins in normal and neoplastic human tissues
9. Reduced connexin43 expression in high-grade human brain glioma cells
10. Perturbation in connexin 43 and connexin 26 gap-junction expression in mouse skin hyperplasia and neoplasia
11. Frequent reduction of gap junctional intercellular communication and connexin43 expression in human and mouse lung carcinoma cells
12. Expression of connexin32 and connexin43 gap junction proteins and E-cadherin in human lung cancer
13. Suppression of tumorigenicity of human lung carcinoma cells after transfection with connexin43
14. Altered gap junctional intercellular communication in neoplastic rat esophageal epithelial cells
15. Aberrant expression, function and localization of connexins in human esophageal carcinoma cell lines with different degrees of tumorigenicity
16. Expression of cell adhesion molecules and connexins in gap junctional intercellular communication deficient human mesothelioma tumour cell lines and communication competent primary mesothelial cells
17. In vivo growth of C6 glioma cells transfected with connexin43 cDNA
18. Transfection of C6 glioma cells with connexin 43 cDNA: Analysis of expression, intercellular coupling, and cell proliferation
19. Gap junction genes cx26 and cx43 individually suppress the cancer phenotype of human mammary carcinoma cells and restore differentiation potential
20. Transfection of rhabdomyosarcoma cells with connexin43 induced myogenic differentiation
21. A connexin 43 antisense vector reduces the ability of normal cells to inhibit the foci formation of transformed cells
22. Inhibition of gap junctional intercellular communication and enhancement of growth in BALB/c 3T3 cells treated with connexin43 antisense oligonucleotides
23. Immortalized connexin43 knockout cell lines display a subset of biological properties associated with the transformed phenotype
24. Apoptosis: An overview
25. Bcl-2 family proteins: Regulators of apoptosis and chemoresistance in hematologic malignancies
26. Double identity for proteins of the Bcl-2 family
27. Egr-1 negatively regulates human tumor cell growth via the DNA-binding domain
28. Multidrug resistance and the lung resistance-related protein in human colon carcinoma SW-620 cells
29. Expression of multidrug resistance protein-3 (multispecific organic anion transporter-D) in human embryonic kidney 293 cells confers resistance to anticancer agents
30. UV activates growth factor receptors via reactive oxygen intermediates
31. Egr-I inhibits apoptosis during the UV response: Correlation of cell survival with Egr-I phosphorylation
32. Suppression of human fibrosarcoma cell growth by transcription factor, Egr-1, involves down-regulation of Bcl-2
33. Decreased Egr-1 expression in human, mouse and rat mammary cells and tissues correlates with tumor formation
34. Rapid disruption of gap junctional communication and phosphorylation of connexin43 by platelet-derived growth factor in T51B rat liter epithelial cells expressing platelet-derived growth factor receptor
35. Reduced expression of pro-apoptotic gene Bax is associated with poor response rates to combination chemotherapy and shorter survival in woman with metastatic breast adenocarcinoma
36. Topoisomerase 11 inhibitors affect entry into mitosis and chromosome condensation in BHK cells
37. 2 to M transition: Implications for gene therapy
38. Reversible inhibition of intercellular junctional communication by glycyrrhetinic acid
39. Glycyrrhetinic acid derivatives: A novel class of inhibitors of gap-junctional intercellular communication. Structure-activity relationships
40. Antiapoptotic Bcl-2 family protein expression increases with progression of oligodendroglioma
41. Bcl-2 protein expression in astrocytomas in relation to patient survival and p53 gene status
42. Hypoxanthine-guanine phosphoribosyltransferase deficiency: Chemical agents selective for mutant or normal cultured fibroblasts in mixed and heterozygote cultures
43. Bystander killing of cancer cells by herpes simplex virus thymidine kinase gene is mediated by connexins
44. Gap junctional communication modulates gene expression in osteoblastic cells
45. Bcl-2 oncoprotein blocks chemotherapy-induced apoptosis in a human leukemia cell line
46. Modulation of Bcl-2 protein levels by an intracellular anti-Bcl- 2 single-chain antibody increases drug-induced cytotoxicity in the breast cancer cell line MCF-7
47. BCL-2 family proteins: Regulators of cell death involved in the pathogenesis of cancer and resistance to therapy
48. Localization and function of the connexin 43 gap-junction protein in normal and various oncogene-expressing rat liver epithelial cells
49. Gap junctions and cell polarity: Connexin32 and connexin43 expressed in polarized thyroid epithelial cells assemble into separate gap junctions, which are located in distinct regions of the lateral plasma membrane domain
50. Tyrosine phosphorylation of connexin 43 by v-Src is mediated by SH2 and SH3 domain interactions
51. In vivo association of pp60v-src and the gap-junction protein connexin 43 in v-src-transformed fibroblasts
52. Gap-junction-mediated propagation and amplification of cell injury